















Danielle Bradbury will join the Triall initiative as advisor Quality and Compliance. She has over 20 years of experience in clinical research and has extensive knowledge of SOP management, GxP inspection readiness, computer system validation, and quality compliance.

Danielle currently is Head of Quality Assurance at Galera Therapeutics where she provides senior strategic quality leadership ensuring quality and compliance across the company. She has over 20 years of experience in clinical research in both academia and industry. Danielle started her career conducting investigator-initiated and sponsored research in the cardiac catheterization lab at the University of Pennsylvania. During her tenure in the lab, she was also a member of the University of Pennsylvania’s Institutional Review Board.

Danielle subsequently worked in the industry as a monitor in trial management and began focusing her career on quality and compliance while working at Johnson & Johnson in the Quality and Compliance Department. She went on to create the North American Clinical Quality Department for Actelion Clinical Research where she provided quality and compliance guidance for global clinical trials followed by BTG International Inc. where she built Global Clinical Quality. She later became the General Manager at InClinica CRO where she oversaw its global clinical operations.

Levering her expertise in SOP management, GxP inspection readiness, computer system validation, and quality compliance, Danielle will support Triall in developing industry-grade product offerings that fully comply with industry standards and international quality guidelines.